Research

Sharpe Ratio: A Complete Guide for Algorithmic Traders

Sharpe is the default metric in systematic trading and the most often abused. The complete practitioner's guide to the math, the gotchas, and what Sharpe does and doesn't tell you.

Sentivue Capital··9 min read

The Sharpe ratio is the most-cited number in systematic trading. It's also the most often abused. Most arguments about Sharpe come down to one of three things: people computing it wrong, people interpreting it wrong, or people optimizing for the wrong number altogether.

What Sharpe actually measures

Sharpe is the excess return per unit of total volatility:

Sharpe = (R_p − R_f) / σ_p

In words: how much extra return do you get for each unit of "wiggle" in the equity curve? It treats the standard deviation of returns as the price of being in the strategy and asks how much the strategy compensates you for that price.

The annualization gotcha

Daily Sharpe is annualized by √252. Hourly by √252 × √hours. Monthly by √12. This is correct only under specific statistical assumptions — primarily, that returns are independent across periods. They almost never are.

Most strategies have positive autocorrelation in their returns (good streaks cluster). When returns are autocorrelated, naive √252 annualization overstates the true annualized Sharpe. The cleanest fix is to compute Sharpe directly at the annual frequency when you have enough years; otherwise apply the autocorrelation correction (Lo, 2002).

Why Sharpe penalizes upside

The denominator is total volatility — both upside and downside. A strategy with a few outsized winners will look worse on Sharpe than a flatter strategy with the same average return. This is conceptually wrong: most investors would rather have the upside outliers.

This is why trend-following and options-selling strategies — both highly asymmetric in opposite directions — produce Sharpe numbers that don't reflect their actual risk-reward profile. For these styles, Sortino and Calmar tell more honest stories. See Sharpe vs Sortino vs Calmar.

Sharpe distribution under the null

A truly edgeless strategy run on noise data does not produce zero Sharpe. It produces a Sharpe distributed around zero with standard error roughly 1 / √T (T = number of return observations). Three years of daily data has a standard error of roughly 0.1 annualized Sharpe.

That means a backtest Sharpe of 0.5 over three years is not significantly different from zero at conventional thresholds. See statistical significance in trading for the full argument.

Reading Sharpe like an institutional allocator

Reported SharpeWhat an experienced allocator hears
< 0.5"Likely overfitting noise"
0.5–1.0"Acceptable; verify it's robust"
1.0–1.5"Solid; how does it survive in stress?"
1.5–2.5"Strong; show me the live track"
2.5–4.0"Very strong — or hiding a tail risk"
> 4.0"Show me the overfitting audit"

The categories shift at higher frequencies. A daily-rebalanced equity stat-arb strategy reasonably claims Sharpe of 2.5+; a multi-month trend program reasonably claims 0.7. Comparing across frequencies is meaningless without adjustment.

What Sharpe does not capture

  • Tail risk. A strategy can have a wonderful Sharpe and still blow up. Short-vol programs are the canonical example.
  • Drawdown depth and duration. Maximum drawdown and Calmar capture this directly.
  • Capacity. Sharpe is computed on the strategy in isolation. The strategy at 10× the size may have a meaningfully worse Sharpe due to market impact.
  • Time-varying edge. A strategy with a 10-year Sharpe of 1.5 might be running at a 2-year Sharpe of 0.0. The lifetime number averages over the live regime.

Practical takeaways

  • Compute Sharpe at the deployment frequency. Annualize from longer-frequency returns when possible.
  • Always pair Sharpe with drawdown metrics. They answer different questions.
  • Don't compare Sharpe across strategies of materially different frequencies without adjustment.
  • A backtest Sharpe of 3+ is a backtest overfitting red flag unless the strategy has a documented economic mechanism that survives scrutiny.

Related